Author:
Slot S,Smits K,van de Donk N W C J,Witte B I,Raymakers R,Janssen J J W M,Broers A E C,te Boekhorst P A W,Zweegman S
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference30 articles.
1. McLornan DP, Mead AJ, Jackson G, Harrison CN . Allogeneic stem cell transplantation for myelofibrosis in 2012. Br J Haematol 2012; 157: 413–425.
2. Abelsson J, Merup M, Birgegård G, WeisBjerrum O, Brinch L, Brune M et al. The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries. Bone Marrow Transplant 2012; 47: 380–386.
3. Deeg HJ, Gooley TA, Flowers ME, Sale GE, Slattery JT, Anasetti C et al. Allogeneic hematopoietic stem cell transplantation for myelofibrosis. Blood 2003; 102: 3912–3918.
4. Ditschkowski M, Elmaagacli AH, Trenschel R, Gromke T, Steckel NK, Koldehoff M et al. DIPSS scores, pre-transplant therapy and chronic GVHD determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis. Haematologica 2012; 97: 1574–1581.
5. Guardiola P, Anderson JE, Bandini G, Cervantes F, Runde V, Arcese W et al. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study. Blood 1999; 93: 2831–2838.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献